- Home
- MIND vs HOWL Comparison
MIND vs HOWL Comparison
Compare MIND & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIND
- HOWL
- Stock Information
- Founded
- MIND 1987
- HOWL 2017
- Country
- MIND United States
- HOWL United States
- Employees
- MIND N/A
- HOWL N/A
- Industry
- MIND Industrial Machinery/Components
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- MIND Industrials
- HOWL Health Care
- Exchange
- MIND Nasdaq
- HOWL Nasdaq
- Market Cap
- MIND 53.6M
- HOWL 50.3M
- IPO Year
- MIND 1994
- HOWL 2021
- Fundamental
- Price
- MIND $6.07
- HOWL $1.21
- Analyst Decision
- MIND
- HOWL Strong Buy
- Analyst Count
- MIND 0
- HOWL 3
- Target Price
- MIND N/A
- HOWL $8.33
- AVG Volume (30 Days)
- MIND 97.6K
- HOWL 643.1K
- Earning Date
- MIND 06-10-2025
- HOWL 05-08-2025
- Dividend Yield
- MIND N/A
- HOWL N/A
- EPS Growth
- MIND N/A
- HOWL N/A
- EPS
- MIND 4.32
- HOWL N/A
- Revenue
- MIND $46,863,000.00
- HOWL $1,143,000.00
- Revenue This Year
- MIND $7.28
- HOWL N/A
- Revenue Next Year
- MIND N/A
- HOWL $900.00
- P/E Ratio
- MIND $1.41
- HOWL N/A
- Revenue Growth
- MIND 28.36
- HOWL N/A
- 52 Week Low
- MIND $3.05
- HOWL $0.60
- 52 Week High
- MIND $11.10
- HOWL $5.73
- Technical
- Relative Strength Index (RSI)
- MIND 41.81
- HOWL 62.51
- Support Level
- MIND $6.21
- HOWL $1.18
- Resistance Level
- MIND $6.62
- HOWL $1.31
- Average True Range (ATR)
- MIND 0.30
- HOWL 0.12
- MACD
- MIND -0.08
- HOWL 0.02
- Stochastic Oscillator
- MIND 5.60
- HOWL 79.59
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.